Innovation Package - ENDOSLEEVE
🇫🇷 Forfait Innovation - Innovation Package 🇫🇷
MediTech is very proud to share the news about the positive HAS evaluation of a breakthrough innovative medical procedure and healthcare technology for the treatment of obese and diabetic patients.
ENDOSLEEVE is intended for type 2 diabetic patients with so-called "moderate" grade I obesity (30 ≤ body mass index (BMI) < 35 kg/m2) with the primary goal of total diabetes remission resulting from procedure-induced weight loss.
Please find the HAS publication on the following link: